Form 4: CFO Rohit Ramchandani's PHLT Stock Transactions

Performant Healthcare CFO Rohit Ramchandani acquired shares from RSU vesting and sold a portion for tax obligations, revealing performance-based equity incentives.

Summary

• Chief Financial Officer Rohit Ramchandani acquired 21,469 shares of Performant Healthcare Inc. (PHLT) common stock on August 14, 2025, through the vesting of Restricted Stock Units (RSUs).
• Concurrently, 10,688 shares were disposed of at a price of $7.615 per share to cover tax liabilities associated with the RSU vesting.
• Following these transactions, the CFO beneficially owns 264,096 shares of common stock.
• The RSU award, granted on August 5, 2024, totals 65,058 units, divided into three tranches with performance-based vesting conditions tied to trailing twelve-month Healthcare revenue.
• Tranche 1 (21,469 RSUs) vested upon achieving a Target Revenue Amount of $135 million.
• Tranche 2 (21,469 RSUs) vests upon achieving $155 million in trailing twelve-month Healthcare revenue within three years from the grant date.
• Tranche 3 (22,120 RSUs) vests upon achieving $175 million in trailing twelve-month Healthcare revenue within four years from the grant date.
• Vesting for all tranches is also contingent on continuous service.

Sentiment

Score: 7

Explanation: The filing indicates the achievement of a performance-based revenue target, leading to RSU vesting for the CFO, which is a positive sign of operational execution. The transaction itself is routine for executive compensation.

Positives

• The vesting of Tranche 1 RSUs indicates that Performant Healthcare Inc. has achieved its $135 million trailing twelve-month Healthcare revenue target.
• The performance-based RSU awards align management incentives with company revenue growth.
• The CFO's continued significant beneficial ownership (264,096 shares) demonstrates ongoing alignment with shareholder interests.

Risks

• Future RSU tranches (Tranche 2 and 3) are subject to forfeiture if the specified revenue targets ($155 million and $175 million, respectively) are not met within their respective timeframes (3 and 4 years from grant date).
• Vesting of future RSU tranches is contingent on the CFO's continuous service, posing a risk if the CFO departs.

Future Outlook

The future outlook for the CFO's equity compensation is directly tied to Performant Healthcare Inc.'s ability to achieve specific trailing twelve-month Healthcare revenue targets of $155 million and $175 million within the next three to four years, respectively. The vesting of these future RSU tranches is also contingent on the CFO's continuous employment.

Industry Context

This filing reflects a standard practice of performance-based equity compensation for executives in the healthcare services industry, aiming to incentivize revenue growth and long-term commitment. The specific revenue targets provide insight into the company's internal growth expectations within the healthcare sector.

Comparison to Industry Standards

• Performance-based Restricted Stock Units (RSUs) tied to revenue targets are a common executive compensation structure across various industries, including healthcare, to align management incentives with company growth.
• The specific revenue targets ($135M, $155M, $175M) are internal company goals for Performant Healthcare Inc. and would need to be compared against similar-sized healthcare revenue cycle management or payment integrity companies like Cotiviti, Change Healthcare (now OptumInsight), or R1 RCM to assess their ambition and feasibility within the industry. Without specific comparable company revenue figures or growth rates, a direct assessment of these targets against industry benchmarks is limited.
• The practice of selling shares to cover tax liabilities upon RSU vesting is standard and widely observed among executives receiving equity compensation.

Stakeholder Impact

• Shareholders: The achievement of the $135 million revenue target for Tranche 1 RSU vesting suggests positive operational performance, which could be favorable for shareholders. The performance-based compensation structure aligns management incentives with shareholder value creation through revenue growth.
• Employees: No direct impact mentioned, but performance-based compensation structures can motivate employees if similar incentives are cascaded.

Next Steps

• Achievement of Tranche 2 Target Revenue Amount of $155 million for vesting of 21,469 RSUs.
• Achievement of Tranche 3 Target Revenue Amount of $175 million for vesting of 22,120 RSUs.
• Continued service of the Chief Financial Officer for future RSU vesting.

Key Dates

Recommendation

This Form 4 filing primarily details routine executive compensation transactions, specifically the vesting of performance-based Restricted Stock Units (RSUs) and the subsequent sale of shares to cover tax liabilities. While the vesting of Tranche 1 RSUs indicates the achievement of a $135 million revenue target, which is a positive operational sign, the filing itself does not contain new material information that would significantly alter the investment thesis for Performant Healthcare Inc. It confirms management's alignment with revenue growth through incentive compensation. Therefore, a "hold" recommendation is appropriate as the filing does not present a compelling reason to buy or sell based solely on this information.

Keywords

Performant Healthcare, PHLT, SEC Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Executive Compensation, CFO, Rohit Ramchandani, Stock Transactions, Performance-Based Equity, Healthcare Revenue